These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 26547719)

  • 21. Outcomes of TB/HIV co-infected patients presenting with antituberculosis drug-induced liver injury.
    Naidoo S; Evans D; Jong E; Mellet K; Berhanu R
    S Afr Med J; 2015 Apr; 105(5):393-6. PubMed ID: 26242667
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Frequency, types, severity, preventability and costs of Adverse Drug Reactions at a tertiary care hospital.
    Geer MI; Koul PA; Tanki SA; Shah MY
    J Pharmacol Toxicol Methods; 2016; 81():323-34. PubMed ID: 27109493
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adverse drug reactions in adult medical inpatients in a South African hospital serving a community with a high HIV/AIDS prevalence: prospective observational study.
    Mehta U; Durrheim DN; Blockman M; Kredo T; Gounden R; Barnes KI
    Br J Clin Pharmacol; 2008 Mar; 65(3):396-406. PubMed ID: 18070223
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monitoring drug safety in Astrakhan, Russia.
    Kirilochev OO; Dorfman IP; Umerova AR
    Int J Risk Saf Med; 2015; 27 Suppl 1():S33-4. PubMed ID: 26639700
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interrater agreement of two adverse drug reaction causality assessment methods: A randomised comparison of the Liverpool Adverse Drug Reaction Causality Assessment Tool and the World Health Organization-Uppsala Monitoring Centre system.
    Mouton JP; Mehta U; Rossiter DP; Maartens G; Cohen K
    PLoS One; 2017; 12(2):e0172830. PubMed ID: 28235001
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment outcomes among patients admitted to hospital with antiretroviral and/or antituberculosis drug-induced liver injury.
    Mehta R; Ive P; Evans D; Menezes CN
    S Afr Med J; 2021 Apr; 111(5):474-481. PubMed ID: 34852891
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adverse drug reactions at adverse drug reaction monitoring center in Raipur: Analysis of spontaneous reports during 1 year.
    Singh P; Agrawal M; Hishikar R; Joshi U; Maheshwari B; Halwai A
    Indian J Pharmacol; 2017; 49(6):432-437. PubMed ID: 29674797
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of Adverse Drug Reactions to First-Line Anti-Tuberculosis Drugs Using the Korea Adverse Event Reporting System.
    Chung SJ; Byeon SJ; Choi JH
    J Korean Med Sci; 2022 Apr; 37(16):e128. PubMed ID: 35470602
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HAART induced adverse drug reactions: a retrospective analysis at a tertiary referral health care center in India.
    Anwikar SR; Bandekar MS; Smrati B; Pazare AP; Tatke PA; Kshirsagar NA
    Int J Risk Saf Med; 2011; 23(3):163-9. PubMed ID: 22020396
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-tuberculosis drugs adverse reactions: a review of the Iranian literature.
    Kargar M; Mansouri A; Hadjibabaie M; Javadi M; Radfar M; Gholami K
    Expert Opin Drug Saf; 2014 Jul; 13(7):875-91. PubMed ID: 24935479
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatic adverse drug reactions: a case/non-case study in Italy.
    Motola D; Vargiu A; Leone R; Cocci A; Salvo F; Ros B; Meneghelli I; Venegoni M; Cutroneo PM; Vaccheri A; Velo G; Montanaro N
    Eur J Clin Pharmacol; 2007 Jan; 63(1):73-9. PubMed ID: 17119945
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adverse drug reaction monitoring in patients on antiretroviral therapy in a tertiary care hospital in Eastern India.
    Mukherjee S; Era N; Saha B; Tripathi SK
    Indian J Pharmacol; 2017; 49(3):223-228. PubMed ID: 29033481
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inter-rater agreement between WHO- Uppsala Monitoring Centre system and Naranjo algorithm for causality assessment of adverse drug reactions.
    More SA; Atal S; Mishra PS
    J Pharmacol Toxicol Methods; 2024; 127():107514. PubMed ID: 38768933
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Does methylphenidate cause liver damage? An analysis of ad hoc reports to the "Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM)"].
    Fekete S; Romanos M; Gerlach M
    Z Kinder Jugendpsychiatr Psychother; 2018 Jul; 46(4):342-348. PubMed ID: 29237323
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Comparison of Adverse Drug Reaction Profiles in Patients on Antiretroviral and Antitubercular Treatment in Zimbabwe.
    Masuka JT; Chipangura P; Nyambayo PP; Stergachis A; Khoza S
    Clin Drug Investig; 2018 Jan; 38(1):9-17. PubMed ID: 28965312
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adverse events to antituberculosis therapy: influence of HIV and antiretroviral drugs.
    Marks DJ; Dheda K; Dawson R; Ainslie G; Miller RF
    Int J STD AIDS; 2009 May; 20(5):339-45. PubMed ID: 19386972
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A prospective analysis of the preventability of adverse drug reactions reported in Sweden.
    Lövborg H; Eriksson LR; Jönsson AK; Bradley T; Hägg S
    Eur J Clin Pharmacol; 2012 Aug; 68(8):1183-9. PubMed ID: 22349466
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Raltegravir for the treatment of patients co-infected with HIV and tuberculosis (ANRS 12 180 Reflate TB): a multicentre, phase 2, non-comparative, open-label, randomised trial.
    Grinsztejn B; De Castro N; Arnold V; Veloso VG; Morgado M; Pilotto JH; Brites C; Madruga JV; Barcellos NT; Santos BR; Vorsatz C; Fagard C; Santini-Oliveira M; Patey O; Delaugerre C; Chêne G; Molina JM;
    Lancet Infect Dis; 2014 Jun; 14(6):459-67. PubMed ID: 24726095
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High Burden of Adverse Drug Reactions to Isoniazid Preventive Therapy in People Living With HIV at 3 Tertiary Hospitals in Uganda: Associated Factors.
    Nanyonga SM; Kitutu FE; Kalyango J; Frank M; Kiguba R
    J Acquir Immune Defic Syndr; 2022 Feb; 89(2):215-221. PubMed ID: 34693930
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictors of adverse drug reaction-related hospitalisation in Southwest Ethiopia: A prospective cross-sectional study.
    Angamo MT; Curtain CM; Chalmers L; Yilma D; Bereznicki L
    PLoS One; 2017; 12(10):e0186631. PubMed ID: 29036230
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.